These goals of this study are to identify the mutations that give rise to inherited Mendelian neurodegenerative disorders in five categories (spastic paraplegia, neuromuscular disorders, movement disorders, ataxia, and non-Alzheimer dementia) and to investigate how these mutations lead to disease. During the past 5 years, there has been a fundamental shift in the approach to gene discovery from linkage analysis-based positional cloning to mutational cloning, made possible by technologies and analysis equipment that perform massively parallel sequencing of DNA. This new approach also relies on the success of the Human Genome Project that provided a template against which to compare the sequences obtained from any individual. Because the great majority of genetic diseases are caused by mutations that affect the protein sequence, this research focuses on the """"""""exome"""""""", the complete protein- coding region of the genome. The challenge of mutational cloning is to identify a pathogenic mutation in the background of thousands of benign protein changing variations in individual exomes. The proposed approach combines linkage or identity-by-descent (IBD) analysis to identify genomic regions shared by all affected family members and exome sequencing of several affected relatives to identify the variants they share in the IBD region. Advances in bioinformatics offer a stepwise filtering approach to select the likely pathogenic variants to study further. Cosegregation of the variant with disease in single families and identification of mutations in the same gene in other families provide validation that the gene is responsible for the disease. In vitro studies of the effect of the mutation on the function of the gene will be done when possible. The research takes advantage of the large collection of samples from many families ascertained, extensively characterized, and extended over the past 25 years. Continued subject accrual is a unifying feature of the proposed research;new disorders are identified, panels of subjects are developed for disease-gene verification, and genotype/phenotype correlations can be determined. Beyond the implication of gene discovery for patients who suffer from a particular disorder, each new gene contributes to our understanding of the complex protein-protein interactions involved in maintenance of the neurologic system and pathways of neurodegeneration. The findings of this research will be an important part of a systematic approach to diagnosis and the eventual treatment and prevention of these diseases.

Public Health Relevance

The goal of this proposal is to identify novel genes that are responsible for Mendelian neurogenic disorders, including ataxias, neuropathies, myopathies, movement disorders, and highly penetrant familial dementia. Genetic diseases of the nervous system are relatively common in the Veteran population and the diseases studied in this research project are both directly and indirectly relevant to Veterans'health. These disorders, and especially dementia, neuropathy and ataxia, disproportionately affect the aging veteran population. Knowledge gained from studies on the biologic causes of the inherited forms of diseases will also increase understanding of more common neurologic disorders and will lead to improved diagnosis, management, and treatment of these and related conditions. Therefore, a better understanding of genetic diseases is pertinent to the long-term medical mission of the VA system.

National Institute of Health (NIH)
Veterans Affairs (VA)
Non-HHS Research Projects (I01)
Project #
Application #
Study Section
Special Emphasis - Research on Clinical Application of Genetics (SPLC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
VA Puget Sound Healthcare System
United States
Zip Code
Domoto-Reilly, Kimiko; Davis, Marie Y; Keene, C Dirk et al. (2017) Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M). Am J Med Genet B Neuropsychiatr Genet 174:70-74
Mata, Ignacio F; Davis, Marie Y; Lopez, Alexis N et al. (2016) The discovery of LRRK2 p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot. Am J Med Genet B Neuropsychiatr Genet 171:925-30
Yuan, Peng; Condello, Carlo; Keene, C Dirk et al. (2016) TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy. Neuron 90:724-39
Chen, Dong-Hui; Below, Jennifer E; Shimamura, Akiko et al. (2016) Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L. Am J Hum Genet 98:1146-1158
Sullivan, Jeremy M; Zimanyi, Christina M; Aisenberg, William et al. (2015) Novel mutations highlight the key role of the ankyrin repeat domain in TRPV4-mediated neuropathy. Neurol Genet 1:e29
Bird, Thomas D; Swanson, Phillip D (2015) Congenital insensitivity to pain with anhidrosis. Ann Neurol 78:500
Barral, Sandra; Vardarajan, Badri N; Reyes-Dumeyer, Dolly et al. (2015) Genetic variants associated with susceptibility to psychosis in late-onset Alzheimer's disease families. Neurobiol Aging 36:3116.e9-3116.e16
Chen, Dong-Hui; Méneret, Aurélie; Friedman, Jennifer R et al. (2015) ADCY5-related dyskinesia: Broader spectrum and genotype-phenotype correlations. Neurology 85:2026-35
Kamat, Siddhesh S; Camara, Kaddy; Parsons, William H et al. (2015) Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay. Nat Chem Biol 11:164-71
Korvatska, Olena; Leverenz, James B; Jayadev, Suman et al. (2015) R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. JAMA Neurol 72:920-7

Showing the most recent 10 out of 16 publications